Vinson & Elkins advised Lexicon Pharmaceuticals, Inc. on the deal. Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”) announced it entered into a securities purchase agreement for a private...
Lexicon Pharmaceuticals’ $250 Million Private Placement of Equity Securities
Lexicon Pharmaceuticals’ $143.7 Million Common Stock Offering
Vinson & Elkins advised Lexicon Pharmaceuticals, while Simpson Thacher represented Invus on the deal. Cooley represented the underwriters for the public offering. Lexicon Pharmaceuticals, Inc. (Nasdaq:...